“White Coat Compliance” Limits the Reliability of Therapeutic Drug Monitoring in HIV-1—Infected Patients
HIV Clinical Trials · 2008-08 · 9 (4) · 238-246
DOI: 10.1310/hct0904-238 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift HIV Clinical Trials, online erschienen am 06.01.2015. Verfasst von Thomas J Podsadecki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Global Pharmaceutical Research and Development , Abbott Laboratories, Abbott Park, Illinois 60064, USA. Thomas.Podsadecki@abbott.com. Hauptthemen laut MEDLINE: HIV-1. Die Arbeit wurde bisher 136-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Global Pharmaceutical Research and Development , Abbott Laboratories, Abbott Park, Illinois 60064, USA. Thomas.Podsadecki@abbott.com
Zitieren
APA
Podsadecki, T. J., Vrijens, B. C., Tousset, E. P., Rode, R. A., & Hanna, G. J. (2008). “White Coat Compliance” Limits the Reliability of Therapeutic Drug Monitoring in HIV-1—Infected Patients. HIV Clinical Trials, 9(4), 238-246. https://doi.org/10.1310/hct0904-238
Vancouver
Podsadecki TJ, Vrijens BC, Tousset EP, Rode RA, Hanna GJ. “White Coat Compliance” Limits the Reliability of Therapeutic Drug Monitoring in HIV-1—Infected Patients. HIV Clinical Trials. 2008;9(4):238-246. doi:10.1310/hct0904-238
BibTeX
@article{Podsadecki2008,
author = {Podsadecki, Thomas J and Vrijens, Bernard C and Tousset, Eric P and Rode, Richard A and Hanna, George J},
title = {“White Coat Compliance” Limits the Reliability of Therapeutic Drug Monitoring in HIV-1—Infected Patients},
journal = {HIV Clinical Trials},
year = {2008},
volume = {9},
number = {4},
pages = {238--246},
doi = {10.1310/hct0904-238}
}
EUVIMED